{"entity":{"id":"kenneth-tanabe","kind":"person","name":"Kenneth K. Tanabe","aka":[],"tldr":"Massachusetts General Hospital surgical oncologist and 2026-2027 President of the Society of Surgical Oncology, with expertise in liver cancer and melanoma.","summary":"Kenneth Tanabe is President of the Society of Surgical Oncology for 2026-2027 and Chief of Surgical Oncology at Massachusetts General Hospital, where he is a professor of surgery at Harvard Medical School. His clinical and research work focuses on hepatobiliary malignancies and melanoma, including hepatocellular carcinoma biology and oncolytic virus therapy. He has held numerous leadership roles in US surgical oncology.","asOf":"2026-09-10","links":[{"label":"Society page","url":"https://www.surgonc.org/about-sso/leadership/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Tanabe+KK%5BAuthor%5D"}],"tags":["leadership","clinician-scientist","surgical oncology","liver cancer"],"related":[],"cancers":["hcc","melanoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["sso"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["annals-of-surgical-oncology"],"dependsOn":[],"notes":[],"role":"President","institutionId":"sso","specialisms":["Surgical oncology","Hepatobiliary cancer","Melanoma"],"profiles":[{"label":"Society page","url":"https://www.surgonc.org/about-sso/leadership/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Tanabe+KK%5BAuthor%5D"}],"papers":[{"title":"Epidermal Growth Factor Gene Functional Polymorphism and the Risk of Hepatocellular Carcinoma in Patients With Cirrhosis","journal":"JAMA","year":2008,"doi":"10.1001/jama.2007.65"},{"title":"Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma","journal":"Annals of Surgical Oncology","year":2019,"doi":"10.1245/s10434-019-07227-9"},{"title":"Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma","journal":"Journal of Clinical Oncology","year":2016,"doi":"10.1200/jco.2015.64.2710"}]},"route":"/people/kenneth-tanabe/","neighbours":{"cancer":[{"id":"hcc","kind":"cancer","name":"Hepatocellular carcinoma","route":"/cancers/hcc/"},{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"}],"institution":[{"id":"sso","kind":"institution","name":"Society of Surgical Oncology","route":"/institutions/sso/"}],"journal":[{"id":"annals-of-surgical-oncology","kind":"journal","name":"Annals of surgical oncology","route":"/journals/annals-of-surgical-oncology/"}]}}